128 related articles for article (PubMed ID: 127968)
1. Comparison of lymphocyte reactivity in patients with cancer, systemic lupus erythematosus and renal allografts.
Suciu-Foca N; Herter FP; Buda JA; Reemtsma K
Oncology; 1975; 31(3-4):125-32. PubMed ID: 127968
[TBL] [Abstract][Full Text] [Related]
2. Impaired cell-mediated immunity in patients with cancer.
Buda JA; Suciu-Foca N; Blomain E; McManus S; Reemtsma K
J Surg Oncol; 1975; 7(6):525-9. PubMed ID: 127091
[TBL] [Abstract][Full Text] [Related]
3. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
4. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
[TBL] [Abstract][Full Text] [Related]
5. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.
Landry M
Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.
Stephens HA; Fitzharris P; Knight RA; Snaith ML
Ann Rheum Dis; 1982 Oct; 41(5):495-501. PubMed ID: 6215003
[TBL] [Abstract][Full Text] [Related]
7. Development of specific nonreactivity in human cadaveric renal allograft recipients.
Sengar DP; Rashid A; Harris JE
Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus.
Foad B; Adams LE; Litwin A; Hess EV
Ann Rheum Dis; 1975 Oct; 35(5):407-14. PubMed ID: 1234408
[TBL] [Abstract][Full Text] [Related]
9. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
Huber C; Pfister R; Stingl G
Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte transformation induced by autologous cells.
Weksler ME; Kuntz MM; Birnbaum G; Innes JB
Fed Proc; 1978 Aug; 37(10):2370-3. PubMed ID: 79505
[TBL] [Abstract][Full Text] [Related]
11. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.
Horwitz DA; Garrett MA; Craig AH
Clin Exp Immunol; 1977 Jan; 27(1):100-10. PubMed ID: 849643
[TBL] [Abstract][Full Text] [Related]
12. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus.
Kuntz MM; Innes JB; Weksler ME
J Clin Invest; 1979 Jan; 63(1):151-3. PubMed ID: 153913
[TBL] [Abstract][Full Text] [Related]
13. Significance of autologous mixed lymphocyte reaction-activated immune circuits for maintaining normal immune system homeostasis in humans.
Sakane T
Jpn J Med; 1985 May; 24(2):188-90. PubMed ID: 3160876
[No Abstract] [Full Text] [Related]
14. Shared antigenic determinants between rabbit antihuman brain and rabbit antihuman thymocyte sera: relationship to the lymphocytotoxic antibodies of systemic lupus erythematosus.
Huntley AC; Fletcher MP; Ikeda RM; Gershwin ME
Clin Immunol Immunopathol; 1977 Mar; 7(2):269-80. PubMed ID: 140777
[No Abstract] [Full Text] [Related]
15. Correlation in hemodialysis patients and renal allograft recipients between percent T lymphocytes in peripheral blood and in vitro lymphocyte responses to nonspecific mitogenic agents.
Sengar DP; Rashid A; Harris JE
Acta Haematol; 1975; 54(3):159-64. PubMed ID: 809959
[TBL] [Abstract][Full Text] [Related]
16. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus.
Crow MK
J Clin Invest; 1985 Aug; 76(2):807-15. PubMed ID: 3161910
[TBL] [Abstract][Full Text] [Related]
18. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
Twomey JJ; Laughter AH; Steinberg AD
J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
20. [T cell functions in rheumatic diseases].
Sakane T; Takada S
Ryumachi; 1982 Aug; 22(4):329-38. PubMed ID: 6217560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
